company background image
PRE logo

Prenetics Global NasdaqGM:PRE Stock Report

Last Price

US$3.57

Market Cap

US$42.9m

7D

-24.0%

1Y

-70.6%

Updated

27 Mar, 2024

Data

Company Financials +

Prenetics Global Limited

NasdaqGM:PRE Stock Report

Market Cap: US$42.9m

Prenetics Global Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Prenetics Global
Historical stock prices
Current Share PriceUS$3.57
52 Week HighUS$16.50
52 Week LowUS$3.25
Beta-0.087
1 Month Change-27.59%
3 Month Change-39.90%
1 Year Change-70.58%
3 Year Changen/a
5 Year Changen/a
Change since IPO-96.94%

Recent News & Updates

Prenetics Global Limited (NASDAQ:PRE) Held Back By Insufficient Growth Even After Shares Climb 30%

Jan 07
Prenetics Global Limited (NASDAQ:PRE) Held Back By Insufficient Growth Even After Shares Climb 30%

Recent updates

Prenetics Global Limited (NASDAQ:PRE) Held Back By Insufficient Growth Even After Shares Climb 30%

Jan 07
Prenetics Global Limited (NASDAQ:PRE) Held Back By Insufficient Growth Even After Shares Climb 30%

Prenetics Global GAAP EPS of -$2.91, revenue of $51.72M

Sep 09

Shareholder Returns

PREUS HealthcareUS Market
7D-24.0%0.04%0.6%
1Y-70.6%8.4%29.5%

Return vs Industry: PRE underperformed the US Healthcare industry which returned 8.4% over the past year.

Return vs Market: PRE underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is PRE's price volatile compared to industry and market?
PRE volatility
PRE Average Weekly Movement10.3%
Healthcare Industry Average Movement7.3%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: PRE's share price has been volatile over the past 3 months.

Volatility Over Time: PRE's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2007400Danny Yeunghttps://www.prenetics.com

Prenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use. The company’s products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; ACTOnco, a comprehensive test that helps clinicians choose the optimal treatment for all major solid tumors; ACTDrug+, a screening test that checks for 40 cancer genes to map drug options and provide treatment strategy options; ACTLung, a test focused on biomarkers associated with lung cancer for targeted therapy; ACTFusion, a test that decodes 13 fusion genes and more than 350 transcripts to map drug options; and ACTCerebra, a genomic profiling service for solid tumors.

Prenetics Global Limited Fundamentals Summary

How do Prenetics Global's earnings and revenue compare to its market cap?
PRE fundamental statistics
Market capUS$42.90m
Earnings (TTM)-US$17.63m
Revenue (TTM)US$279.64m

0.2x

P/S Ratio

-2.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PRE income statement (TTM)
RevenueUS$279.64m
Cost of RevenueUS$146.55m
Gross ProfitUS$133.10m
Other ExpensesUS$150.72m
Earnings-US$17.63m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-1.47
Gross Margin47.60%
Net Profit Margin-6.30%
Debt/Equity Ratio0%

How did PRE perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.